Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale
Authors
Keywords
Atrial fibrillation, Factor Xa inhibitor, Warfarin, Stroke, Meta-Analysis
Journal
AMERICAN HEART JOURNAL
Volume 233, Issue -, Pages 48-58
Publisher
Elsevier BV
Online
2020-12-06
DOI
10.1016/j.ahj.2020.12.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Multiplicity Considerations in Clinical Trials
- (2018) Alex Dmitrienko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis
- (2018) Chris Cameron et al. Journal of Comparative Effectiveness Research
- Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
- (2017) Kuo‐Li Pan et al. Journal of the American Heart Association
- Thrombus Aspiration in ST-Segment–Elevation Myocardial InfarctionClinical Perspective
- (2016) Sanjit S. Jolly et al. CIRCULATION
- Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ
- (2016) Danielle L. Burke et al. STATISTICS IN MEDICINE
- Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure
- (2016) Gianluigi Savarese et al. JACC-Heart Failure
- Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment
- (2015) Hwanhee Hong et al. STATISTICS IN MEDICINE
- Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
- (2014) Dipak Kotecha et al. LANCET
- Conceptual and Technical Challenges in Network Meta-analysis
- (2013) Andrea Cipriani et al. ANNALS OF INTERNAL MEDICINE
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
- (2010) John W. Eikelboom et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
- (2009) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started